US20160324175A1 - Dairy Salt, Method for its Production and Food Products Containing It - Google Patents
Dairy Salt, Method for its Production and Food Products Containing It Download PDFInfo
- Publication number
- US20160324175A1 US20160324175A1 US15/106,697 US201415106697A US2016324175A1 US 20160324175 A1 US20160324175 A1 US 20160324175A1 US 201415106697 A US201415106697 A US 201415106697A US 2016324175 A1 US2016324175 A1 US 2016324175A1
- Authority
- US
- United States
- Prior art keywords
- acid
- potassium
- salt
- composition
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 127
- 235000013365 dairy product Nutrition 0.000 title claims abstract description 66
- 235000013305 food Nutrition 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims description 119
- 238000004519 manufacturing process Methods 0.000 title claims description 57
- 239000000203 mixture Substances 0.000 claims abstract description 117
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 94
- 239000011591 potassium Substances 0.000 claims abstract description 94
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 94
- 238000001728 nano-filtration Methods 0.000 claims abstract description 48
- 239000012528 membrane Substances 0.000 claims abstract description 46
- 238000001223 reverse osmosis Methods 0.000 claims abstract description 46
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 39
- 239000011734 sodium Substances 0.000 claims abstract description 39
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 39
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 37
- 229930195729 fatty acid Natural products 0.000 claims abstract description 37
- 239000000194 fatty acid Substances 0.000 claims abstract description 37
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 37
- 150000007524 organic acids Chemical class 0.000 claims abstract description 36
- 230000000873 masking effect Effects 0.000 claims abstract description 35
- 235000013351 cheese Nutrition 0.000 claims abstract description 34
- 239000012466 permeate Substances 0.000 claims abstract description 32
- 239000012465 retentate Substances 0.000 claims abstract description 28
- 238000011282 treatment Methods 0.000 claims abstract description 28
- 150000001413 amino acids Chemical class 0.000 claims abstract description 27
- 235000000346 sugar Nutrition 0.000 claims abstract description 25
- 238000000909 electrodialysis Methods 0.000 claims abstract description 20
- 239000011148 porous material Substances 0.000 claims abstract description 20
- 238000001035 drying Methods 0.000 claims abstract description 18
- 238000001914 filtration Methods 0.000 claims abstract description 12
- 239000000796 flavoring agent Substances 0.000 claims abstract description 11
- 238000009928 pasteurization Methods 0.000 claims abstract description 10
- 108010046377 Whey Proteins Proteins 0.000 claims description 63
- 102000007544 Whey Proteins Human genes 0.000 claims description 62
- 239000000126 substance Substances 0.000 claims description 61
- 239000005862 Whey Substances 0.000 claims description 58
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 57
- 239000011707 mineral Substances 0.000 claims description 57
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 54
- 239000008101 lactose Substances 0.000 claims description 54
- 239000000047 product Substances 0.000 claims description 47
- 235000018102 proteins Nutrition 0.000 claims description 28
- 102000004169 proteins and genes Human genes 0.000 claims description 28
- 108090000623 proteins and genes Proteins 0.000 claims description 28
- 235000001014 amino acid Nutrition 0.000 claims description 26
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 235000011888 snacks Nutrition 0.000 claims description 17
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 14
- 235000005985 organic acids Nutrition 0.000 claims description 14
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 10
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 10
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 10
- 239000005642 Oleic acid Substances 0.000 claims description 10
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 10
- 235000021314 Palmitic acid Nutrition 0.000 claims description 10
- 235000021355 Stearic acid Nutrition 0.000 claims description 10
- 239000011575 calcium Substances 0.000 claims description 10
- 229910052791 calcium Inorganic materials 0.000 claims description 10
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 10
- 239000004310 lactic acid Substances 0.000 claims description 10
- 235000014655 lactic acid Nutrition 0.000 claims description 10
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 10
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 10
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 10
- 239000008117 stearic acid Substances 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 235000021313 oleic acid Nutrition 0.000 claims description 9
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 9
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 8
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 8
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 8
- 235000013922 glutamic acid Nutrition 0.000 claims description 8
- 239000004220 glutamic acid Substances 0.000 claims description 8
- 239000004474 valine Substances 0.000 claims description 8
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 7
- 244000061456 Solanum tuberosum Species 0.000 claims description 7
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 7
- 239000011777 magnesium Substances 0.000 claims description 7
- 229910052749 magnesium Inorganic materials 0.000 claims description 7
- 239000011574 phosphorus Substances 0.000 claims description 7
- 229910052698 phosphorus Inorganic materials 0.000 claims description 7
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 6
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 6
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 claims description 6
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 6
- 235000020778 linoleic acid Nutrition 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- 235000005135 Micromeria juliana Nutrition 0.000 claims description 5
- 235000007315 Satureja hortensis Nutrition 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 5
- 229930182830 galactose Natural products 0.000 claims description 5
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 4
- 235000011194 food seasoning agent Nutrition 0.000 claims description 4
- 235000011087 fumaric acid Nutrition 0.000 claims description 4
- 235000006408 oxalic acid Nutrition 0.000 claims description 4
- 150000008163 sugars Chemical class 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 235000021357 Behenic acid Nutrition 0.000 claims description 3
- 239000004278 EU approved seasoning Substances 0.000 claims description 3
- 235000011054 acetic acid Nutrition 0.000 claims description 3
- 235000021342 arachidonic acid Nutrition 0.000 claims description 3
- 229940114079 arachidonic acid Drugs 0.000 claims description 3
- 229940116226 behenic acid Drugs 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- ZINJLDJMHCUBIP-UHFFFAOYSA-N ethametsulfuron-methyl Chemical compound CCOC1=NC(NC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(=O)OC)=N1 ZINJLDJMHCUBIP-UHFFFAOYSA-N 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 239000001530 fumaric acid Substances 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- 239000002002 slurry Substances 0.000 claims description 2
- 241000246354 Satureja Species 0.000 claims 2
- 239000002994 raw material Substances 0.000 abstract description 49
- 239000012141 concentrate Substances 0.000 abstract description 46
- 235000013336 milk Nutrition 0.000 abstract description 41
- 239000008267 milk Substances 0.000 abstract description 41
- 210000004080 milk Anatomy 0.000 abstract description 41
- 238000012545 processing Methods 0.000 abstract description 27
- 235000013361 beverage Nutrition 0.000 abstract description 8
- 230000002829 reductive effect Effects 0.000 abstract description 8
- 235000013606 potato chips Nutrition 0.000 abstract description 5
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 235000014505 dips Nutrition 0.000 abstract description 2
- 235000012495 crackers Nutrition 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 description 134
- 230000008569 process Effects 0.000 description 61
- 235000010755 mineral Nutrition 0.000 description 47
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 33
- 239000011780 sodium chloride Substances 0.000 description 24
- 239000000243 solution Substances 0.000 description 16
- 238000000108 ultra-filtration Methods 0.000 description 15
- 150000002597 lactoses Chemical class 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 230000009467 reduction Effects 0.000 description 14
- 239000007795 chemical reaction product Substances 0.000 description 13
- 238000009938 salting Methods 0.000 description 13
- 230000036961 partial effect Effects 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 9
- 230000008030 elimination Effects 0.000 description 8
- 238000003379 elimination reaction Methods 0.000 description 8
- 239000003925 fat Substances 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 238000009434 installation Methods 0.000 description 8
- 239000012266 salt solution Substances 0.000 description 8
- 230000014759 maintenance of location Effects 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000005018 casein Substances 0.000 description 5
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 5
- 235000021240 caseins Nutrition 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 235000021119 whey protein Nutrition 0.000 description 5
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 150000001805 chlorine compounds Chemical class 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 238000005115 demineralization Methods 0.000 description 4
- 230000002328 demineralizing effect Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 229910001415 sodium ion Inorganic materials 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000007738 vacuum evaporation Methods 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical class [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 240000002114 Satureja hortensis Species 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000013622 meat product Nutrition 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 229920005597 polymer membrane Polymers 0.000 description 3
- 235000013580 sausages Nutrition 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000005393 Sodium-Potassium-Exchanging ATPase Human genes 0.000 description 2
- 108010006431 Sodium-Potassium-Exchanging ATPase Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000003916 acid precipitation Methods 0.000 description 2
- 230000009056 active transport Effects 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 235000015241 bacon Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000005454 flavour additive Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000012432 intermediate storage Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000013310 margarine Nutrition 0.000 description 2
- 239000003264 margarine Substances 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- -1 salt sodium chloride Chemical class 0.000 description 2
- 238000013515 script Methods 0.000 description 2
- 230000014860 sensory perception of taste Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000064622 Physalis edulis Species 0.000 description 1
- 235000001982 Physalis edulis Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000014089 extruded snacks Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 150000002238 fumaric acids Chemical class 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000020129 lassi Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000011169 microbiological contamination Methods 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 150000002913 oxalic acids Chemical class 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000030883 sensory perception of salty taste Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000018405 transmission of nerve impulse Effects 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000007279 water homeostasis Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1425—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of whey, e.g. treatment of the UF permeate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/144—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by electrical means, e.g. electrodialysis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/84—Flavour masking or reducing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention pertains to the food and beverage industry. It can be used in the production of any number of food or beverage products, including dairy products (various types of cheese, including fresh (of the Queso Fresco type) and cottage cheese), products of the confectionery and baking industries, chips, products in whose production addition of salt is prescribed (cooked sausage, smoked sausage, smoked cheese, ham, cold cuts, meat products, etc.), soups, dips, and sauces.
- dairy products various types of cheese, including fresh (of the Queso Fresco type) and cottage cheese
- chips products in whose production addition of salt is prescribed (cooked sausage, smoked sausage, smoked cheese, ham, cold cuts, meat products, etc.), soups, dips, and sauces.
- Table salt has historically been used in the production of food products as a taste additive and natural preservative. Salty is one of the five basic tastes, together with sweet, sour, bitter and umami. Several types of salt are known, depending on their origin, type of processing and degree of grinding of the mineral having the chemical formula NaCl.
- the salt sodium chloride (NaCl) is an important element that ensures human and animal vitality.
- the most important mechanism of active transport in animal cells is the so-called sodium-potassium pump, connected with a difference in the concentration gradient of K + and Na + ions outside and inside the cell.
- Sodium as part of salt is one of the essential elements for accomplishing vitally important functions of the human body. About 50% of all the sodium in our body is found in the extracellular fluid, 40% in bones and cartilage, about 10% in cells. Sodium forms part of bile, blood, cerebrospinal fluid, pancreatic juice, mother's milk. It is also necessary for normal function of nerve endings, transmission of nerve impulses and muscular activity, including the heart muscle, and also for assimilation of certain nutrients by the small intestine and kidneys.
- Chlorine in turn participates in the formation of special substances that promote splitting of fats. Necessary for the formation of hydrochloric acid (the main component of gastric juice), it takes care of eliminating urea from the body, stimulates function of the reproductive and central nervous systems, promotes formation and growth of bone tissue. Human muscle tissue contains 0.20-0.52% chlorine, bone tissue—0.09%; most of this trace element is contained in blood and extracellular fluid.
- Sodium ions (Na + ), potassium ions (K + ) and chloride ions (Cl ⁇ ) predominate in extracellular and intracellular fluids. More than a third of the ATP consumed by an animal cell in a state of rest is consumed to pump sodium and potassium.
- the significance of the sodium-potassium pump for the life of each cell and the body as a whole is determined by the fact that continuous pumping out of sodium from the cell and injection of potassium into it are necessary for many vitally important processes: osmoregulation in retention of cell volume, maintaining a potential difference on both sides of the membrane, support of electrical activity in nerve and muscle cells, for active transport to membranes of other substances (sugars, amino acids). Large amounts of potassium are also required: protein synthesis, glycolysis, photosynthesis and other processes.
- Milk which is a natural product of the mammal body, has the most optimal ratio of sodium, potassium and chlorine concentrations in its composition, for which reason dairy salt obtained during processing of milk represents the most optimal alternative to table salt.
- Preliminary processing of milk raw material is conducted to reduce the risk of spoiling of the raw material and an increase effectiveness of subsequent baromembrane processes and includes purification on separators-purifiers, purification on vibrating screens, thermization or pasteurization.
- Ultrafiltration is a membrane separation process conducted at a pressure of 0.2 to 5 bar with membrane elements with a pore diameter from 10 to 100 nm. Ultrafiltration in the dairy industry is used for standardization and normalization of milk according to fat-protein ratio (in preparing concentrates for cheese production), concentration of the protein-carbohydrate/protein fraction of milk/whey (in the production of various concentrates).
- Nanofiltration is a membrane separation process conducted at a pressure of 1 to 20 bar with membrane elements with a pore diameter from 1 to 10 nm. It is used for concentration of milk raw material, partial demineralization. During NF treatment concentration of macromolecules (protein, fat) and also lactose occurs, whereas mineral salts and partly lactose enter the permeate.
- RO Reverse osmosis
- Electrodialysis is a membrane process occurring under the influence of an electric field.
- the principle of the electrodialysis process consists of selective passage of individual charged ions through ion exchange membranes under the influence of an external current force.
- the membranes have selectivity and do not allow ions to pass through in the opposite direction.
- the process is used in industry for partial or complete demineralization of raw material.
- whey salts as a component for salting of food products is known (RU 94010413 A23B4/00 Apr. 20, 1996).
- Whey is used as part of the salt composition in order to enrich the product with biogenic substances of milk (mineral salts, carbohydrates, etc.): meat or fish raw material is subjected to salting with table salt and then steeping in a whey solution occurs (for example 1 L per 1 kg of fish/meat) in order to enrich it and subject it to maturation.
- Salting of a food product by steeping causes significant consumption of whey per unit product.
- This invention is only applicable for meat and fish raw material.
- a method for producing a salt solution from milk raw material and whey salt prepared by the given method (RU 2308196 A23C9/142 Jun. 27, 2005).
- Whey salt is obtained from the permeate obtained from ultrafiltration of milk.
- the UF permeate is concentrated by nanofiltration followed by filtration on a reverse osmosis unit.
- the obtained RO retentate containing dry substance from 1 to 3% is also a solution of dairy salts.
- This invention represents an integrated approach to processing all the constituents of milk and modification of the composition of the finished product with allowance for the requirements of persons suffering from lactose intolerance, but does not deal with the question of producing salts from whey.
- the dairy salts obtained according to this method are not the main desired component, bur serve merely as a secondary component in the preparation in the preparation of drinkable milk.
- the salt solution has low concentration, which makes its transport complicated and economically unjustified. Ultrafiltration of whole milk can also lead to losses of fat owing to concentration polarization phenomena on the membrane module and also destabilization phenomena and aggregation of fat globules during mechanical effects.
- a composition for salting of meat products and a method for its preparation from whey are known (RU 2468586 A23B4/02 Jul. 28, 2010).
- the composition includes whey mineralizate, table salt and sodium nitrite in proportions of 5000:1250:2.36. Its use during salting by introducing a complex of whey salts leads to a reduction in content of sodium salts and enrichment of the product with components useful to the human body contained in milk.
- the whey mineralizate is obtained from whey which is subject to electrodialysis treatment, the obtained concentrate is sent to concentration and/or drying, producing a product either in liquid form with a content of dry substance of 3-50% or in dry form with a content of dry substance of 95-98%.
- a dairy salt concentrate and method for its production are known (http://www.dairy salt.com/en/the-dairy salt-range/replacing-salt-with-dairy salt, http://www.accessdata.fda.gov/scripts/fcn/gras_notices/GRN376.pdf).
- This concentrate can be used as a substitute or additive to table salt in the preparation of different food products in order to reduce total consumption of sodium chloride in the diet while retaining taste properties.
- the dairy salt concentrate is obtained from UF permeate (from ultrafiltration of acid whey of defatted milk after acid precipitation of casein). The obtained UF permeate is subjected to filtration on a reverse osmosis installation. KOH is added to the obtained RO permeate, centrifuged and concentrated on a vacuum evaporator with subsequent drying.
- the finished concentrate of milk minerals has the following composition: mineral salts 78-88% (including sodium 8-10%, potassium 28-30%, chlorides 40-45%, calcium 2.5-3%), lactose 5-9%, protein 1%, fat—less than 0.5%, free moisture—2 to 5%.
- the claimed method of production does not involve the use of whey obtained in industrial processes of cottage cheese and cheese production.
- This technology does not permit a lactose content to be achieved in the product of more than 15%, whereas according to a number of proposals it is precisely the lactose content in the dry concentrate of dairy salts that promotes a reduction of total bitterness in organoleptic perception.
- a lactose salt is known which is concentrate of whey salts (http://www.accessdata.fda.gov/scripts/fcn/gras_notices/grn000052.pdf), which in dry form is used as a source of milk calcium in food additives, in different enriched products and beverages.
- whey salts http://www.accessdata.fda.gov/scripts/fcn/gras_notices/grn000052.pdf
- the dry concentrate contains 79% minerals, including phosphorus (in the form of phosphate)—41% and calcium—24%, organic compounds in the form of citrates—9%, protein—5%, lactose—9%, fat—less than 0.5%.
- a method for production of a concentrate of mineral salts from milk (U.S. Pat. No. 5,185,166 Feb. 9, 1993, Nakagawa et al.).
- the raw material for its production is whey.
- the method for production of the concentrate of lactose salts includes concentration of whey by ultrafiltration on membrane elements with a cutoff threshold relative to molecular weight of 40,000 Daltons (which corresponds to a pore diameter of the membrane of 0.01-0.05 ⁇ m) to a lactose content of 50%, elimination of lactose by centrifuging and in the case of production of concentrate in dry form, drying of the obtained salt solution.
- the finished dry concentrate has the following composition: lactose 38-60%, protein 1 to 3%, mineral substance 20-35% (including potassium 2-10%, calcium 2-5%, sodium 2.5-5%, magnesium 0.2-0.5%, phosphorus 0.1-5% and also trace amounts of iron, zinc, manganese and copper).
- This concentrate can be used as an additive for different beverages, including juices owing to its transparency and high biological value of the mineral composition. But at the same time its use as a taste additive or substitute for table salt is limited as a result of the low content of potassium and chlorides.
- Performance of whey concentration when performed by the membrane method is irrational to achieve more than 58% dry substance, since it requires an extensive time and leads to massive “contamination” of the membrane elements with particles of organic compounds (for example, large protein or fat molecules), and the process of settling of the concentrate for crystallization of lactose from it is also a lengthy processing operation. In the case of a slight increase in temperature during this process a rapid rise in acidity and a potential risk of microbiological contamination are possible.
- the closest analog to the claimed invention is dry whey salt and a method for its preparation (WO 99/40798 A23C 21/00, A23L 1/237, 1/304, August 1999).
- This object contains natural minerals of whey and can be used as a partial substitute for table salt.
- Cheese, cottage cheese or casein whey and also permeate from milk or whey can be used as raw material.
- the method for production of dry whey salt includes concentration of the raw material by nanofiltration on membranes with a cutoff threshold of 150-300 daltons (which corresponds to a pore diameter of the membrane of 0.001-0.0001 ⁇ m) at a temperature of 20° C. and a pressure of 22 bar, filtration of the NF permeate on a reverse osmosis installation and drying, or concentration after reverse osmosis treatment and drying.
- the finished dry salt produced according to this method contains potassium (19-27%), calcium (0.5-2%), sodium (5-7%), magnesium (0.1-1%), chlorides (17-37%), phosphorus (0.5-3%), protein (10-20%), lactose (10-35%).
- This salt does not have a bitter taste, which distinguishes it from artificially produced compositions from individual mineral components in similar ratios and can be used as a substitute for ordinary table salts for salting of food and food products.
- the possibility of using only concentration for treatment of the NF permeate offered by this method is difficult and poorly effective as a result of the low content of dry substance in this raw material.
- the load on the vacuum evaporator is significantly increased and the energy costs are increased.
- the pressure value higher than 20 bar during nanofiltration could also promote rapid wear of the membrane element and impose additional strength requirements on the material and type of design of the membrane.
- An increase in working pressure in the membrane installation also causes an increase in load on the pumps and, as a result, increases the energy costs of production.
- Salt with a lactose content no lower than 10% is obtained according to this method, whereas in the production of a number of products it is necessary to use a salt with reduced lactose content (less than 10%).
- the low lactose level can be caused not only by the processing characteristic of the products, but also the need for absence of a “milk” taste, the carrier of which is mostly lactose.
- FIG. 1 Diagram of preparation of complex dairy salt with a lactose content of 1-10%.
- FIG. 2 Diagram of preparation of complex dairy salt with a lactose content of 30-70%.
- the tasks of the claimed inventions are to develop an effective ecologically safe method for processing whey and to produce from it a complex lactose salt of variable composition having increased organoleptic quality and ensuring a balanced ratio of sodium, potassium, calcium salts when used in food products, which is necessary for complete assimilation of the food product by a living organism.
- the raw material from producing the salt composition can be cottage cheese whey obtained in the production of cottage cheese by the conventional or separator method, whey from production of granulated cottage cheese, permeate following production of cottage cheese by the ultrafiltration method, cheese whey, permeate, obtained during ultrafiltration of milk in the production of fresh cheese.
- This raw material is a byproduct in the production of such products as cottage cheese, cheese, casein, and various preconcentrates.
- Mineral salts of lactose are found as a true solution, which makes their isolation possible and economically justified by means of membrane methods according to the claimed scheme.
- the salt blend composition includes potassium, magnesium, calcium, chloride and sulfate ions, lactic acid and its salts, non-protein nitrogenous substances, lactose. All these components are of natural origin, i.e., are contained in native form in the initial milk raw material.
- the balanced content of potassium, chloride, sodium ions in the complex salt obtained according to the claimed method ensures satisfaction of the needs of the body for minerals.
- whey or milk raw material 110 , 210 in the method 100 , 200 for production of the complex lactose salt 190 , 270 is initially subjected to preliminary treatment 120 , 220 in pasteurization for purification and preparation for further processing, whereupon nanofiltration 130 , 230 , reverse osmosis (RO) 140 , 240 and electrodialysis treatment 150 are conducted in succession ( FIG. 1 ) or mixing of the RO retentate 245 and NF retentate 235 without performing electrodialysis ( FIG. 2 ), producing a dairy salt concentrate 190 , 270 for subsequent concentration 170 or concentration 250 and drying 260 .
- RO reverse osmosis
- This production scheme not only ensures a high degree of transfer of biologically valuable milk components from the initial raw material to the end product, but permits a unique composition to be obtained in the high organoleptic indices suitable for widespread use in the food industry. This is explained by the selectivity of separation of the components of the raw material in various membrane processes and the production conditions that ensure productivity of the operations and high retention of the most important nutrients.
- Mineral salts in the dry substance of the raw material occupy from 10 to 20%.
- baromembrane methods of processing milk raw material are used: ultrafiltration, nanofiltration, reverse osmosis, electrodialysis.
- the raw material is initially purified on filters and then sent to a vibrating screen to eliminate large parts of the casein dust, which prevent effective baromembrane treatment. They are then pasteurized under the following conditions:
- the milk raw material is cooled to the intermediate storage temperature or, in the case of a continuous processing method, to the temperature of the membrane process of 20-50° C.
- Membrane treatment of the raw material is carried out on installations of different types, mostly roller installations user polymer membranes.
- the nanofiltration and reverse osmosis processes can be conducted on a single installation which includes different membrane modules of centrifugal pumps connected in sequence.
- Various types of polymer membranes can be used for nanofiltration.
- the type of membrane comes from the manufacturer of the equipment, the most widespread installations are from the DSS, Alpma and other companies.
- the size of the pores is chosen from 0.01 to 0.001 ⁇ m.
- polymer membranes are used (for example from the KOCH Co.) with a cutoff threshold of about 400 daltons, which corresponds to a pore diameter of 0.0001-0.001 ⁇ m (1-10 nm).
- the process pressure is established in the range 30-40 bar.
- the nanofiltration process is run at a temperature from 20 to 40° C. and a pressure of 5 to 20 bar, which stems from the need to ensure optimal rheological characteristics of the raw material and also the need to prevent an increase in acidity of the raw material at an elevated temperature.
- the initial milk raw material 110 , 210 is separated into a retentate 132 , 235 , mostly containing lactose, protein, an insignificant amount of mineral substances, and a permeate 134 , 232 , mostly containing lactose and mineral substances.
- a permeate 134 , 232 mostly containing lactose and mineral substances.
- a reverse osmosis process 140 , 240 is used for concentration of the salt solution.
- Preliminary concentration is economically justified and rational, since it permits a reduction in time and energy costs, which can develop during processing on a vacuum evaporator owing to elimination of additional moisture.
- the NF permeate 134 , 232 obtained as a result of the process with a content of dry substances of 0.4-0.7% is sent to reverse osmosis 140 , 240 , whose membrane module has a pore diameter of 0.0001-0.001 ⁇ m.
- Filtration process is run at a pressure of 10-40 bar and a temperature of 10-15° C.
- the high applied pressure in the process is explained by the need to overcome the osmotic pressure of the solvent (in this case water), to ensure passage of solvent molecules through the semipermeable membrane.
- the obtained RO retentate 142 can also be subjected to electrodialysis 150 treatment.
- Electrodialysis 150 is run in order to free the RO retentate 142 of lactose.
- the process is run at temperatures of 15-25° C., which ensures optimal rheological characteristics of the solutions while retaining conditions that prevent a rapid increase in acidity.
- separation of the incoming stream occurs to a salt concentrate 160 and a partially/fully desalted diluate 155 .
- the process is run on an electrodialysis unit (for example, Mega).
- the retentate 245 obtained after reverse osmosis filtration 240 is mixed with the nanofiltration retentate 235 in proportions of 1:25, 1:20, 1:15, etc. in a stream or through a vessel before the surge tank of the vacuum evaporator.
- the NF retentate 235 is mostly a source of lactose 236 and whey protein.
- the high content of these components in the salt is technologically preferred in the case of production of different types of products, for example, crackers or chips, in which flavorings are introduced. Lactose, whey protein and lipids are a base for application of aromatic substances and their distribution along the surface of the end product.
- a vacuum evaporation process is used.
- the concentrate obtained as a result of reverse osmosis treatment (with electrodialysis or without it) is sent to concentration in a vacuum evaporator.
- the secondary steam of each housing (except for the last) in the multihousing evaporator unit is used to heat the next housing.
- the vacuum in the evaporators is created as a result of condensation of secondary stem in water cooled condensers.
- Use of multihousing vacuum evaporators is most effective from the standpoint of steam economy; use of partial vacuum during concentration permits the use of lower temperatures in comparison with evaporation at atmospheric pressure and avoids the critical effect of high temperatures on thermolabile components of the raw material.
- the concentration process is stopped when a weight fraction of dry substance of 35-40% is reached in the concentrate.
- the production process is stopped and the obtained concentrate used or sent to a dryer, for example, of the spray type.
- the process is completed when a weight fraction of water in the end product of 2-5% is reached.
- the complex lactose salt in dry form is more convenient for transport and storage and can also be used in processes where salting of the product with a salt solution is unacceptable and use of salt only in dry form is necessary.
- the production methods 100 including preliminary treatment 120 of the raw material 110 , its concentration by nanofiltration 130 , filtration of the obtained NF permeate 134 through a membrane module of a reverse osmosis unit 140 , electrodialysis 150 of the obtained RO retentate 142 , with concentration 170 of the concentrate 160 and its drying 180 , permits a dry salt 190 of the following composition to be obtained.
- the method for production 200 including preliminary treatment 220 of the milk raw material 210 , pasteurization and subsequent concentration by nanofiltration 230 , filtration of the obtained NF permeate 232 through a membrane module of a reverse osmosis unit 240 , mixing of the obtained RO retentate 245 with the NF retentate 235 , with subsequent concentration 250 of the obtained mixture and its drying 260 permit a dry salt 270 with the following composition to be obtained:
- dairy products granulated cottage cheese, cheeses, etc.
- chips confectionary products
- meat products sausage, hams, etc.
- the product prepared using this component has higher biological value in comparison with a product in which table salt is used.
- the content of sodium is reduced and the taste perception improved.
- salt depending on the process for the specific product is possible by adding a concentrate with 35-40% dry substance (after vacuum evaporation) in a mixing vessel when mixing of all the recipe components occurs, or by the method of sprinkling dry salt powder. It is also possible to produce an intermediate salt solution of the dried complex dairy salt for salting.
- the complex dairy salt is produced by several methods, depending on the final content of components in the composition and also the type of use—in dry or liquid form.
- a complex lactose salt weighed in an amount of 270 tons with a temperature of 12° C. obtained in the production of cheese is sent by pipeline to preliminary treatment on an AMCKO vibrating sieve with a pore size of 40 ⁇ m in order to eliminate large protein particles, whereupon it is heated to a temperature of 40 ⁇ 2° C. in the first section of a pasteurization-cooling unit of the plate type (PPOU-10000) and then subjected at this temperature to centrifugal purification on a separator-purifier for defatting of the whey of the brand MSI 350-01-772 at a drum rotational speed of 6000 rpm in order to eliminate fat.
- the whey purified in this way in an amount of 270 tons is sent by pipeline to the second section of the pasteurization-cooling unit of the plate type, where it is pasteurized at a temperature of 68 ⁇ 2° C. with holding for 10 seconds in order to ensure microbiological purity during subsequent treatment.
- the whey is then cooled to a temperature of 10 ⁇ 2° C. in the cooling section.
- the pasteurized cooled whey is then sent by pipeline to the nanofiltration unit (Alpma) with a pore size of 0.001 ⁇ m equipped with a membrane filter (KOCH) with a pore size of 0.001.
- the whey is concentrated at a temperature of 10 ⁇ 2° C., a flow rate of the whey of 500 kg/h.
- a specific selective membrane filter (0.001 ⁇ m) separation of whey occurs into an NF retentate in which mostly protein remains and partially lactose, and an NF permeate, into which the lactose, mineral salts, fine protein fractions enter. Concentration occurs to a protein content in the retentate of 1.8%.
- the concentration factor of the process is 3.5.
- the obtained NF retentate in an amount of 78.5 tons is collected in individual tanks and then used in other processes (production of whey protein concentrates).
- the NF permeate obtained as a result of the nanofiltration process in an amount of 191.5 tons with a content of dry substance of 0.45% is sent to reverse osmosis treatment for partial concentration and elimination of moisture.
- Membrane modules (KOCH) with a pore diameter of 0.0001 ⁇ m are used for the reverse osmosis treatment, which corresponds to a cutoff threshold relative to molecular weight of 400 daltons.
- a pressure of 40 bar is established.
- the whey under pressure ensured by the action of pumps, is sent from the intermediate vessel by pipeline directly to the membrane module.
- NF permeate During passage through the pores of the reverse osmosis membrane the NF permeate is separated into two fractions: only solvent molecules (water) pass through the pores in the membrane (permeate) but ions of inorganic compounds, lactose, protein, organic acids remain on the surface, which together with part of the water from the solution of RO retentate.
- the RO permeate obtained after the reverse osmosis treatment in an amount of 162 t, containing 0.05% dry substance represents technical water and is subsequently used in other processes (rinsing and cleaning of surfaces of process equipment and rooms).
- the RO retentate obtained during the process in an amount of 29.5 tons with 3.4% dry substance is sent to a diluate vessel of the electrodialysis unit (Mega) for partial elimination of lactose.
- the concentrate vessel of the electrodialysis unit is filled with an equivalent amount of distilled water.
- the electrodialysis process is run at a temperature of 12° C., current intensity 1.1 A, voltage 52 V; the flow rate of the diluate, concentrate and electrolyte are set at 700/h, 700 L/h, 500 L/h respectively. Sensors of electrical conductivity of the solutions are installed in the circulating contours for the diluate and concentrate.
- the electrical conductivities of the diluate and concentrate emerging from its solutions change as a result of modification to their composition.
- the main contribution to total electrical conductivity is made by the mineral salts.
- the demineralization level has reached about 80%. The process is stopped, when this demineralization level is reached based on the ratio of initial and final electrical conductivity values in the diluate solution.
- the obtained ED diluate in an amount of 18 ton, which represents low-concentrated aqueous lactose solution, is then used in other processes.
- the concentrate obtained after electrodialysis in an amount of 11.5 tons is sent to a multihousing vacuum evaporator Vigand-8000 for partial elimination of water and concentration of dry substance.
- the evaporation temperatures of the first and second stages are set at 75° C. and 52° C. respectively.
- the vacuum values during the process are set in the range 85 ⁇ 1 kPa.
- the concentrate of the complex dairy salt in an amount of 2.8 tons is then sent to a dryer of the spray type (for example, Al—OR2Ch).
- the power of the metering pump is set at a value of 0.6 m 3 /h, the vacuum in the drying chamber 50 Pa, air temperature at the input 177° C., air temperature at the output 90° C.
- the drying process is run for 7 hours to a moisture content of 3%.
- a complex dairy salt is obtained in dry form in an amount of 1 ton whose composition includes: mineral salt 72%, protein 12%, organic acids 6%, lactose 7%, water—remainder.
- 200 tons cottage cheese whey is used as raw material to produce a complex dairy salt in concentrated form. All the processing operations are carried out as in example 1, excluding the drying process.
- a concentrate of complex dairy salt is obtained in an amount of 2 tons with 40% dry substance.
- the dry substance includes: mineral salt 74%, protein 12.4%, organic acids 6.2%, lactose 7.4%.
- 400 tons of a mixture obtained by mixing 300 tons cheese whey and 100 tons cottage cheese whey are used to produce a complex dairy salt.
- the preliminary treatment, pasteurization and nanofiltration operations of the whey are conducted similar to the operations described in example 1.
- the NF retentate obtained after nanofiltration in an amount of 118 tons is collected in individual tanks and used partially for mixing with RO retentate after concentration and also in other processes (preparation of whey protein concentrates).
- the obtained NF permeate with a content of 0.47% dry substance in an amount of 282 t is sent to reverse osmosis unit (Alpma) for partial concentration and elimination of moisture.
- the reverse osmosis treatment is conducted similar to the process described in example 1.
- the RO permeate obtained after reverse osmosis treatment in an amount of 264 tons with 0.05% dry substance represents technical water and is then used in other processes (for example, rinsing and cleaning of surfaces of the process equipment and rooms).
- the obtained RO retentate in an amount of 18 tons is mixed in an intermediate vessel with 0.8 tons NF retentate obtained earlier in the nanofiltration process.
- the obtained mixture is sent to a multihousing vacuum evaporator Vigand-8000 for partial elimination of water and concentration of dry substance.
- the evaporation temperatures of the first and second stages are set at 75° C. and 52° C. respectively.
- the vacuum during the process is set in the range 80-90 kPa.
- samples of the concentrated solution are taken to establish the degree of concentration. After about 6 hours the process is stopped when the dry substance reaches 40% in the solution.
- the obtained dairy salt concentrate in an amount of 4.3 tons contains 40% dry substance. It is then sent to a dryer of the spray type (for example, Al-OR2Ch).
- the power of the metering pump is set at a value of 0.6 m 3 , the vacuum in the drying chamber at 50 Pa, the air temperature at the input is 177° C., the air temperature at the output 90° C.
- the drying process is run to a moisture content of 3% within 10 hours.
- a complex dairy salt is obtained in dry form in an amount of 1.5 tons including 37% mineral salt, 4% protein, 3% organic acids, 53% lactose, water—remainder.
- a concentrate of complex lactose salt is obtained in an amount of 4.3 tons with 40% dry substance.
- the dry substance includes 38% mineral salts, 4.1% protein, 3% organic acids, 54.6% lactose.
- Dry complex lactose salt obtained according to the method mentioned in example 1.
- Composition 72% mineral salts, 12% protein, 6% organic acids, 7% lactose, 3% water.
- Dry complex lactose salt obtained according to the method mentioned in example 3.
- Composition 37% mineral salts, 4% protein, 3% organic acids, 53% lactose, remainder—water.
- cow's milk in an amount of 13.3 tons purified on a bactofuge is sent to the first section of a plate heat transfer unit (Tetra Therm Lacta), heated to 50 ⁇ 2° C. and then separated on a separator-cream separator into cream and defatted milk.
- Cottage cheese grain is obtained from the defatted milk in an amount of 8 tons according to the standard process (Tikhomirova, N. A., Technology and organization of milk and dairy product production, textbook, Moscow: DeLi print, 2007).
- the cream obtained after separation in an amount of 4.64 tons is collected in an individual vessel and then used in other processes.
- the cream obtained after separation in an amount of 0.66 tons is normalized to a fat content of 10%, complex lactose salt with 7% lactose (according to example 5) is introduced to it in an amount of 16 kg and sent to a sterilizing unit of the tubular type (Tetra Therm Aseptic Flex) for homogenization at a temperature of 60° C. at a pressure of 170 bar and sterilization at a temperature of 136 ⁇ 2° C. with holding for 4 seconds.
- Introduction of the salt promotes better retention of the cream (as a result of an increase in osmotic pressure of the medium) and improves the organoleptic properties of the end product.
- the cottage cheese grain in an amount of 1 ton is mixed in a mixer with sterilized cream in an amount of 660 kg, into which complex dairy salt was previously introduced.
- An end product is obtained—granulated cottage cheese in an amount of 1 ton.
- Salting of the fried potato is carried out in a coating machine (A2-TK2L).
- the dried complex dairy salt with a lactose content of 53% obtained according to example 6 is spread in an amount of 90 kg on the surface of the potato in the working chamber of the machine.
- dairy salt promotes a reduction in sodium content in the end product in comparison with a traditional production method and also improves the organoleptic properties of the product.
- Replacement of sodium with potassium also increases by a logical value of the product because of the overall reduction in consumption of sodium salts and enrichment of the diet of potassium salts necessary for normal functioning of the cardiovascular system.
- An end food product salted with lactose salt is obtained—natural potato chips in an amount of 1 ton.
- a flavoring additive (bacon) is applied to the dairy salt in an amount of 20.5 kg.
- Use of complex dairy salt with high content of lactose as a base for the flavoring composition promotes better distribution of the aromatic substances along the surface of the product. There is no need to introduce additional carriers to the potato for aromatic substances, like lactose, glucose or milk protein, which promotes significant economy.
- An end product is obtained—potato chips with bacon flavor in an amount of 1.6 tons.
- a steamless dough production scheme on a continuous line is used, for example, QN-280.
- High-grade wheat flour in an amount of 956.5 kg is fed to a dough mixer.
- activation of yeasts is carried out: pressed yeasts in an amount of 32.76 kg are placed in a vessel, ground, mixed with a certain amount of water, prescribed for the batch (60 kg) at a temperature of 32° C. and held for 30 minutes. The activated yeasts are fed to the dough mixing machine.
- Preparation of an emulsion is carried out in a separate vessel.
- Molasses in an amount of 21.44 kg, margarine previously heated at 45° C. in an amount of 139.3 kg, complex dairy salt with 53% lactose (according to example 6) in an amount of 8 kg, water in an amount of 70 kg are introduced to the vessel.
- the mixture is held at a temperature of 30° C. and fed to an emulsifier, where it is mixed for 1 minute and then fed to the dough mixer.
- the dough batch is produced in the dough mixer at a temperature of 35° C.
- the finished dough is rolled out on a molding machine for rolling and cutting, after which the dough is sent for formation of blanks to a forming machine where rolling of the forms occurs in order to avoid formation of large bubbles and swelling of the dough.
- the crackers are baked in a hot air cabinet of the tunnel type at a temperature of 270 ⁇ 2° C. for 3 minutes. After baking the crackers are immediately sprayed with molten fat (margarine) according to the formula. The end products are cooled on a conveyor to 40° C. and packed in the consumer package.
- molten fat margarine
- the end product has reduced sodium content in comparison with crackers prepared with table salt. Its organoleptic properties are improved by introducing milk components (protein, lactose).
- the complex dairy salt obtained according to the method mentioned in example 4 is used to product “table” crackers.
- example 10 It differs from example 10 in that instead of dried complex dairy salt, concentrate of complex dairy salt containing 40% dry substance (according to example 4) is introduced to the mixing vessel in an amount of 19.2 kg. Use of concentrate facilitates dissolution and mixing of the components with a small amount of formula water.
- Another aspect of this disclosure relates to a method of making another dairy salt or potassium-based composition, which contains a masking fraction that is able to conceal or minimize the off-flavor contributed by potassium.
- the term or phrase “potassium-based composition” is used interchangeably with the terms or phrases “potassium-rich composition” and “potassium composition.” These terms refer to an alternative dairy salt composition, which can be used to salt products and thereby create food products (whether in liquid, solid, or semi-liquid form) with a reduced sodium content and without the off-taste of potassium, as compared to an equivalent food product not salted or combined with the potassium composition described below.
- the off-flavor of potassium is masked by the presence of certain compounds, which make up what is termed here as the “masking fraction.”
- the method comprises the steps of i) combining potassium and sodium at a ratio of greater than about 2.0 to form a mineral component; ii) combining the mineral component with the masking fraction to make a potassium-based composition, the masking fraction concealing an off-flavor of the potassium, said masking fraction comprising: a) an organic acid portion substantially consisting of lactic acid; b) an amino acid portion consisting of one or more amino acids selected from the group consisting of: glycine, valine, and glutamic acid; c) a fatty acid portion substantially consisting of one or more fatty acids selected from the group consisting of: myristic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid; and d) a sugar portion consisting of one or more sugars; in a weight ratio of the organic acid portion:the amino acid portion:the fatty acid portion:the sugar portion of about 6-9:0.1-0.4:0.25-1.25:0.5-2.5, wherein said weight ratio is as
- the sodium and potassium combined in combining step i) come from sodium chloride and potassium chloride, respectively.
- sodium and potassium may come from any number of safe-to-ingest forms.
- the potassium and sodium may be combined at a ratio of greater than about 2.5 to form the mineral component.
- the potassium and sodium may be combined at a ratio of between about 2.0 to about 11.
- chloride may also form part of the mineral component.
- the mineral component comprises one or more of: calcium, magnesium, phosphorus, and sulfate. Such additional components may be present in an amount up to about 15% of the potassium-based composition in one embodiment.
- the mineral component comprise one or more of the additional components calcium, magnesium, phosphorus, and sulfate in an amount up to about 6%.
- the combining step ii) comprises about 85% to about 95% of the mineral component in the potassium-based composition, on a dry weight basis. In one embodiment, the combining step ii) comprises about 90% of the mineral component in the potassium-based composition, on a dry weight basis. Table 4, below, depicts a sample composition of a mineral component described herein (dry weight basis).
- the organic acid portion “substantially consisting” of lactic acid means that the organic acid portion comprises lactic acid in an amount of at least about 60%. In one embodiment, the organic acid portion comprises a maximum amount of about 95%. In one embodiment, the organic acid portion comprises lactic acid in an amount of between about 60% to about 95%. In one embodiment, the organic acid portion consists of lactic acid. In one embodiment, other organic acids selected from the group consisting of citric acid, acetic acid, formic acid, fumaric acid, and oxalic acid may also be present within affecting the taste. Thus, in one embodiment, the organic acid portion may also comprise one or more of citric acid, acetic acid, formic acid, fumaric acid, and oxalic acid.
- the potassium-based composition comprises between about 6% to about 9% of the organic acid portion. In one embodiment, the potassium-based composition comprises about 7.5% of the organic acid portion.
- Organic Acid Component Amount Lactic Acid ⁇ 5.0 g/100 g
- the potassium-based composition should comprise a masking fraction with an amino acid portion consisting of one or more amino acids selected from the group consisting of: glycine, valine, and glutamic acid.
- the amino acid portion consists of two or more the amino acids selected from the group consisting of: glycine, valine, and glutamic acid.
- the amino acid portion consists of all three of the amino acids selected from the group consisting of: glycine, valine, and glutamic acid.
- the potassium-based composition should comprise a masking fraction with between about 0.1% to about 0.4% of the amino acid portion. In one embodiment, the potassium-based composition comprises about 0.25% of the amino acid portion.
- the amino acid portion helps modify the salty taste perception of a consumer and synergistically drive salty taste. Table 6, below, a sample amino acid portion of the potassium based composition described herein.
- the fatty acid portion “substantially consisting” of one or more fatty acids selected from the group consisting of: myristic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid means that the fatty acid portion comprises at least one of the listed fatty acids in an amount of at least about 80%.
- the fatty acid portion substantially comprises two or more fatty acids selected from the group consisting of: myristic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid, where substantially consisting of means an amount of at least 80%.
- the fatty acid portion substantially comprises three or more fatty acids selected from the group consisting of: myristic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid, where substantially consisting of means an amount of at least 80%. In one embodiment, the fatty acid portion substantially comprises four or more fatty acids selected from the group consisting of: myristic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid, where substantially consisting of means an amount of at least 80%.
- the fatty acid portion substantially comprises all five of the fatty acids selected from the group consisting of: myristic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid, where substantially consisting of means an amount of at least 80% of all five acids in the fatty acid portion.
- the fatty acid portion may comprise one or more of heptadecanoic acid, arachidic acid, behenic acid, arachidonic acid, and euric acid. These additional fatty acids may be present in a maximum amount of about 15% of the fatty acid portion.
- the potassium-based composition comprises a masking fraction with between about 0.25% to about 1.25% fatty acid portion. In one embodiment, the potassium-based composition comprises a masking fraction of about 0.75% fatty acid portion. Table 7, below, depicts a sample portion of the fatty acid portion described herein.
- the masking fraction of the potassium-based composition should comprise a sugar portion, having only sugars.
- the potassium-based composition comprises between about 0.5% to about 2.5% of the sugar portion relative to the entire potassium-based composition. In one embodiment, the potassium-based composition comprises about 1.5% of the sugar portion.
- the sugar portion substantially consists of (or comprises primarily) two sugars-isomaltulose and galactose. As used herein, substantially consisting of isomaltulose and galactose means at least about 95% isomaltulose and galactose in the sugar portion. Table 8, below, depicts a sample sugar portion of the potassium-based composition.
- a potassium-based composition as described herein may comprise or consist of the components in Tables 4-8.
- the components of the masking fraction, and the disclosed ranges or additions of same may be present in any number of combinations, within the ranges provided herein, while still successfully masking the off-taste provided by potassium.
- a sample masking fraction as a percentage of the mineral component is as follows.
- a snack food product is made using the method and potassium-based composition described herein.
- the method for making a snack food product comprises the steps of: i) combining potassium and sodium at a ratio of greater than about 2.0 to form a mineral component; ii) combining the mineral component with a masking fraction to mask an off-flavor of the potassium and form a potassium-rich composition with said masking fraction, wherein the masking fraction comprises: a) an organic acid portion substantially consisting of lactic acid; b) an amino acid portion consisting of one or more amino acids selected from the group consisting of: glycine, valine, and glutamic acid; c) a fatty acid portion substantially consisting of one or more fatty acids selected from the group consisting of: myristic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid; and d) a sugar portion consisting of one or more sugar; in a weight ratio of the organic acid portion:the amino
- the dairy salt or potassium-based composition once prepared, may be combined with an edible substance or substances for ultimate consumption, to create a food or liquid product having reduced sodium, as compared to one without the dairy salt described herein.
- the above definitions and amounts of each portion of the masking fraction apply for the method of making a snack food product.
- the combining step may be adding the potassium composition onto the surface of an already salted potato chip. Such addition has resulted, for example, to achieve up to about a 40% reduction in sodium during sample preparation and test runs (vs. product seasoned with sodium chloride alone).
- the combining step comprises mixing the potassium-rich composition with its masking fraction into an oil slurry for topical application onto said snack food product.
- the method comprises the step of combining the potassium-rich composition having the masking fraction with one or more seasonings prior to the step of topically adding the potassium-rich composition onto the surface of a snack food product.
- Such combining step has resulted, for example, in a sodium reduction of about 30%, as compared to an equivalent food product not incorporating the potassium composition or dairy salt described herein.
- the potassium composition or dairy salt described herein may be combined with any edible substance in any form ranging from liquid to solid, regardless of moisture content, thereby reducing sodium content of the edible substance for ultimate consumption.
- the edible substance is savory.
- the edible substance(s) may comprise a moisture content of less than about 5%.
- the edible substance for example, may be a cooked or shelf-stable snack food product such as a chip, extruded snack food, or puffy snack food.
- the edible substance may be a high-moisture snack food product, comprising a moisture content of at least about 25%.
- the edible substance may be a high-moisture snack food product, comprising a moisture content of at least about 50%.
- such high-moisture snack food product may be selected from the group consisting of oatmeal, cheese dips, salsa, and beverage.
- the edible substance is in powder form and may be mixed with the potassium-rich composition in dry form.
- the above disclosed composition provides for a solution to addresses the off-taste of potassium perceived by consumers, while reducing sodium in a food product, offering between about 5% to about 40% sodium reduction in food vs. a product seasoning with a sodium salt (such as sodium chloride) alone.
- the potassium composition disclosed herein provides for between about 22% to about 30% reduction in sodium without the perception of any off-flavor. In some embodiments, the potassium composition disclosed herein provides for between about 15% to about 25% reduction in sodium.
- the resulting potassium composition described herein further provides the benefit of an enhanced flavor profile of a resulting snack food, enhancing dairy notes.
- the composition described herein is useful when combined with dairy products such as cheese seasonings.
- the potassium-rich composition may be added to any number of ingestible substances, whether in solid, semi-solid, or liquid form, thereby reducing sodium of the product to be consumed.
- Suitable ingestible substances include any savory product including without limitation shelf-stable, ready-to-eat snack foods such as chips or crackers, cheese dips, salsa, oat-based product including oatmeal or oatmeal-like products, beverages, lassi, tomato juice, broths, soups, pre-pared boxed mixes such as Rice-A-Roni® and Pasta-A-Roni®, and poha.
- the potassium-rich composition described herein is added into an ingestible substance during preparation and prior to final cooking steps.
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Water Supply & Treatment (AREA)
- Dairy Products (AREA)
- General Preparation And Processing Of Foods (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Seasonings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013157311 | 2013-12-24 | ||
RU2013157311/10A RU2555522C1 (ru) | 2013-12-24 | 2013-12-24 | Комплексная молочная соль, способы ее получения и содержащие ее пищевые продукты |
PCT/US2014/067948 WO2015099960A1 (en) | 2013-12-24 | 2014-12-01 | Dairy salt, method for its production and food products containing it |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/067948 A-371-Of-International WO2015099960A1 (en) | 2013-12-24 | 2014-12-01 | Dairy salt, method for its production and food products containing it |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/923,281 Division US11259536B2 (en) | 2013-12-24 | 2020-07-08 | Dairy salt, methods for its production and food products containing it |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160324175A1 true US20160324175A1 (en) | 2016-11-10 |
Family
ID=53479524
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/106,697 Abandoned US20160324175A1 (en) | 2013-12-24 | 2014-12-01 | Dairy Salt, Method for its Production and Food Products Containing It |
US16/923,281 Active US11259536B2 (en) | 2013-12-24 | 2020-07-08 | Dairy salt, methods for its production and food products containing it |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/923,281 Active US11259536B2 (en) | 2013-12-24 | 2020-07-08 | Dairy salt, methods for its production and food products containing it |
Country Status (9)
Country | Link |
---|---|
US (2) | US20160324175A1 (ru) |
EP (1) | EP3086651A4 (ru) |
CN (1) | CN106102468A (ru) |
AU (1) | AU2014370344B2 (ru) |
BR (1) | BR112016014855A2 (ru) |
CA (1) | CA2931956A1 (ru) |
MX (1) | MX2016008365A (ru) |
RU (1) | RU2555522C1 (ru) |
WO (1) | WO2015099960A1 (ru) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170044473A1 (en) * | 2015-07-15 | 2017-02-16 | Velo Acciai S.r.l. | Multi-stage filtration apparatus and filtration method for heterogeneous food admixtures |
US11185084B2 (en) * | 2017-04-11 | 2021-11-30 | Intercontinental Great Brands Llc | Method for the manufacture of a flavor-enhancing composition |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017098058A1 (en) * | 2015-12-10 | 2017-06-15 | Dominick O'reilly | Method for extraction of lactose from whey or a whey mixture |
CN107352265B (zh) * | 2016-11-18 | 2019-04-16 | 浙江一益医疗器械有限公司 | 一种不锈钢无菌针管除污、去油、电解、消磁自动生产线 |
DK3476222T3 (da) | 2017-10-24 | 2020-08-10 | Dmk Deutsches Milchkontor Gmbh | Kvarkgrundmasse med lavt mineralindhold |
RU2658441C1 (ru) * | 2017-12-27 | 2018-06-21 | Акционерное общество "Молочный комбинат "Ставропольский" | Способ получения молочного сахара с поточной кристаллизацией лактозы |
RU2683868C1 (ru) * | 2018-11-30 | 2019-04-02 | Акционерное общество "Молочный комбинат "Ставропольский" | Способ производства молочного сахара |
CN115989835A (zh) * | 2021-10-20 | 2023-04-21 | 内蒙古伊利实业集团股份有限公司 | 具有活性蛋白营养的低糖低盐乳制品及其制备方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3787216A (en) * | 1971-01-04 | 1974-01-22 | Borden Co | Powdered fat composition |
US4216244A (en) * | 1978-09-19 | 1980-08-05 | Allen Alfred E Jr | Low sodium salt seasoning |
US5679390A (en) * | 1995-07-27 | 1997-10-21 | Conover; Donald Robert | Composition and method for making/using a natural fat-free, deep-fried flavoring |
US5853792A (en) * | 1996-05-28 | 1998-12-29 | Dead Sea Works Ltd | Low sodium edible salt composition and process for its preparation |
US20030032600A1 (en) * | 2001-03-05 | 2003-02-13 | Ulrich Stephen A. | Taste masked liquid pharmaceutical compositions |
US20040033573A1 (en) * | 2000-05-30 | 2004-02-19 | Birgir Norddahl | Method for producing lactic acid |
US20070292592A1 (en) * | 2006-06-15 | 2007-12-20 | Mccormick & Company | Salt replacing composition, process for its preparation and food systems containing such composition |
US20080226790A1 (en) * | 2007-03-14 | 2008-09-18 | Concentrate Manufacturing Company Of Ireland | Long chain fatty acids for reducing off-taste of non-nutritive sweeteners |
US20110262618A1 (en) * | 2008-11-28 | 2011-10-27 | Dieter Werner Melwitz | Pureed herbs, vegetables and/or spices composition and process for preparing it |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3860732A (en) * | 1970-03-30 | 1975-01-14 | Cumberland Packing Corp | Salt substitute |
DE3867308D1 (de) | 1987-05-20 | 1992-02-13 | Chugai Pharmaceutical Co Ltd | Salzersatz und dieses enthaltende nahrungsmittel. |
SU1567148A1 (ru) * | 1987-09-11 | 1990-05-30 | Истринское Отделение Всесоюзного Научно-Исследовательского И Конструкторского Молочного Института | Способ получени минеральной добавки из молочного сырь дл обогащени пищевых продуктов |
JPH02265456A (ja) * | 1989-04-04 | 1990-10-30 | Aron World:Kk | 食塩組成物 |
FI104783B (fi) * | 1998-02-12 | 2000-04-14 | Valio Oy | Herasuolajauhe, menetelmä sen valmistamiseksi ja sen käyttö |
FI115752B (fi) * | 2002-05-14 | 2005-07-15 | Valio Oy | Menetelmä käytettäväksi vähälaktoosisen tai laktoosittoman maitotuotteen valmistamiseksi |
US20070166447A1 (en) * | 2002-08-27 | 2007-07-19 | Select Milk Producers, Inc. | Dairy compositions and method of making |
US20040101612A1 (en) * | 2002-11-27 | 2004-05-27 | South Dakota State University | Salt whey product and method of making |
WO2006023812A1 (en) | 2004-08-20 | 2006-03-02 | Cargill Incorporated | Ingredient systems comprising trehalose, food products containing trehalose, and methods of making same |
US7820225B2 (en) * | 2007-03-07 | 2010-10-26 | Exportadora De Sal, S.A. De C.V. | Low sodium salt compositions and methods of preparation and uses thereof |
UA65464U (ru) * | 2011-04-26 | 2011-12-12 | Национальный Университет Пищевых Технологий | Способ производства концентрата сыворотки |
-
2013
- 2013-12-24 RU RU2013157311/10A patent/RU2555522C1/ru active
-
2014
- 2014-12-01 CA CA2931956A patent/CA2931956A1/en not_active Abandoned
- 2014-12-01 CN CN201480070766.5A patent/CN106102468A/zh active Pending
- 2014-12-01 EP EP14874520.1A patent/EP3086651A4/en not_active Withdrawn
- 2014-12-01 MX MX2016008365A patent/MX2016008365A/es unknown
- 2014-12-01 WO PCT/US2014/067948 patent/WO2015099960A1/en active Application Filing
- 2014-12-01 US US15/106,697 patent/US20160324175A1/en not_active Abandoned
- 2014-12-01 BR BR112016014855A patent/BR112016014855A2/pt not_active IP Right Cessation
- 2014-12-01 AU AU2014370344A patent/AU2014370344B2/en not_active Ceased
-
2020
- 2020-07-08 US US16/923,281 patent/US11259536B2/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3787216A (en) * | 1971-01-04 | 1974-01-22 | Borden Co | Powdered fat composition |
US4216244A (en) * | 1978-09-19 | 1980-08-05 | Allen Alfred E Jr | Low sodium salt seasoning |
US5679390A (en) * | 1995-07-27 | 1997-10-21 | Conover; Donald Robert | Composition and method for making/using a natural fat-free, deep-fried flavoring |
US5853792A (en) * | 1996-05-28 | 1998-12-29 | Dead Sea Works Ltd | Low sodium edible salt composition and process for its preparation |
US20040033573A1 (en) * | 2000-05-30 | 2004-02-19 | Birgir Norddahl | Method for producing lactic acid |
US20030032600A1 (en) * | 2001-03-05 | 2003-02-13 | Ulrich Stephen A. | Taste masked liquid pharmaceutical compositions |
US20070292592A1 (en) * | 2006-06-15 | 2007-12-20 | Mccormick & Company | Salt replacing composition, process for its preparation and food systems containing such composition |
US20080226790A1 (en) * | 2007-03-14 | 2008-09-18 | Concentrate Manufacturing Company Of Ireland | Long chain fatty acids for reducing off-taste of non-nutritive sweeteners |
US20110262618A1 (en) * | 2008-11-28 | 2011-10-27 | Dieter Werner Melwitz | Pureed herbs, vegetables and/or spices composition and process for preparing it |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170044473A1 (en) * | 2015-07-15 | 2017-02-16 | Velo Acciai S.r.l. | Multi-stage filtration apparatus and filtration method for heterogeneous food admixtures |
US10316279B2 (en) * | 2015-07-15 | 2019-06-11 | Velo Acciai S.r.l. | Multi-stage filtration apparatus and filtration method for heterogeneous food admixtures |
US11185084B2 (en) * | 2017-04-11 | 2021-11-30 | Intercontinental Great Brands Llc | Method for the manufacture of a flavor-enhancing composition |
Also Published As
Publication number | Publication date |
---|---|
CA2931956A1 (en) | 2015-07-02 |
AU2014370344A1 (en) | 2016-06-16 |
EP3086651A4 (en) | 2017-09-20 |
AU2014370344B2 (en) | 2018-04-26 |
US11259536B2 (en) | 2022-03-01 |
EP3086651A1 (en) | 2016-11-02 |
RU2555522C1 (ru) | 2015-07-10 |
BR112016014855A2 (pt) | 2017-08-08 |
MX2016008365A (es) | 2017-01-09 |
RU2013157311A (ru) | 2015-06-27 |
US20200337325A1 (en) | 2020-10-29 |
CN106102468A (zh) | 2016-11-09 |
WO2015099960A1 (en) | 2015-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11259536B2 (en) | Dairy salt, methods for its production and food products containing it | |
CN101842018B (zh) | 酪蛋白的生产方法 | |
CN103491790B (zh) | 乳基产品及其制备方法 | |
AU2017311557B2 (en) | Process for producing infant formula products and dairy products | |
CN102595915A (zh) | 乳清蛋白产品及其制备方法 | |
US11116233B2 (en) | Process for producing infant formula products and acidic dairy products from milk | |
US20140314935A1 (en) | Fermented flavoring system derived from greek yogurt processing | |
JPWO2010116686A1 (ja) | 脱塩乳の製造方法、脱塩乳 | |
Khezri et al. | Whey: characteristics, applications and health aspects | |
US20140322170A1 (en) | Fermented Flavoring System Derived from Greek Yogurt Processing | |
Ramos et al. | Whey: generation, recovery, and use of a relevant by-product | |
Craig | Dairy Derived Food Ingredients–Functional and Nutritional Considerations | |
RU2793406C2 (ru) | Способ получения продуктов для детского питания и молочных продуктов | |
JP6934529B2 (ja) | 風味増強組成物の製造方法 | |
RU2793288C2 (ru) | Способ получения продуктов для детского питания и кисломолочных продуктов из молока | |
KR20230008135A (ko) | 운동 능력 증진을 위한 단백질-강화 음료 | |
CN116725195A (zh) | 乳清蛋白制品及其制备方法 | |
Skryplonek et al. | Processing technology and the industrial application of whey |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: WIMM-BILL-DANN OJSC, RUSSIAN FEDERATION Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DUDAREV, GRIGORIY A.;GRAVINA, STEPHEN;KALIAPPAN, SIVARAJ;AND OTHERS;SIGNING DATES FROM 20160502 TO 20160518;REEL/FRAME:038961/0275 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |